Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A James

Showing results (161-170 of 293) with videos related to

Pageof 30
Sort By:
Brain Communications|March 18, 2024
Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19Cameron D Owens, Camila Bonin Pinto, Sam Detwiler, et al.
Lupus Science & Medicine|April 15, 2017
Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupusTeresa Aberle, Rebecka L Bourn, Hua Chen, et al.
Annals of the Rheumatic Diseases|September 19, 2024
Human hypofunctional <i>NCF1</i> variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1<sup>+</sup> monocytes-derived macrophagesXinran Yuan, Xiaodong Qin, Kenji Takemoto, et al.
Nature Communications|July 27, 2018
Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networksRichard C Pelikan, Jennifer A Kelly, Yao Fu, et al.
Science Translational Medicine|August 28, 2015
IgH sequences in common variable immune deficiency reveal altered B cell development and selectionKrishna M Roskin, Noa Simchoni, Yi Liu, et al.
BMC Public Health|June 14, 2023
CATCH-UP vaccines: protocol for a randomized controlled trial using the multiphase optimization strategy (MOST) framework to evaluate education interventions to increase COVID-19 vaccine uptake in OklahomaAmanda E Janitz, Jordan M Neil, Laura A Bray, et al.
Lupus Science & Medicine|November 28, 2025
Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activityMelissa E Munroe, Kendra Young, Rufei Lu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical FeaturesMelissa E Munroe, Kendra A Young, Diane L Kamen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 17, 2023
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialJoan T Merrill, Joel Guthridge, Miles Smith, et al.
Plos One|February 12, 2015
Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpuraContessa E Edgar, Deirdra R Terrell, Sara K Vesely, et al.
Pageof 30

Showing results (161-170 of 293) with videos related to

Sort By:
Pageof 30
Brain Communications|March 18, 2024
Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19Cameron D Owens, Camila Bonin Pinto, Sam Detwiler, et al.
Lupus Science & Medicine|April 15, 2017
Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupusTeresa Aberle, Rebecka L Bourn, Hua Chen, et al.
Annals of the Rheumatic Diseases|September 19, 2024
Human hypofunctional <i>NCF1</i> variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1<sup>+</sup> monocytes-derived macrophagesXinran Yuan, Xiaodong Qin, Kenji Takemoto, et al.
Nature Communications|July 27, 2018
Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networksRichard C Pelikan, Jennifer A Kelly, Yao Fu, et al.
Science Translational Medicine|August 28, 2015
IgH sequences in common variable immune deficiency reveal altered B cell development and selectionKrishna M Roskin, Noa Simchoni, Yi Liu, et al.
BMC Public Health|June 14, 2023
CATCH-UP vaccines: protocol for a randomized controlled trial using the multiphase optimization strategy (MOST) framework to evaluate education interventions to increase COVID-19 vaccine uptake in OklahomaAmanda E Janitz, Jordan M Neil, Laura A Bray, et al.
Lupus Science & Medicine|November 28, 2025
Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activityMelissa E Munroe, Kendra Young, Rufei Lu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical FeaturesMelissa E Munroe, Kendra A Young, Diane L Kamen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 17, 2023
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialJoan T Merrill, Joel Guthridge, Miles Smith, et al.
Plos One|February 12, 2015
Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpuraContessa E Edgar, Deirdra R Terrell, Sara K Vesely, et al.
Pageof 30